October 6, 2017

Around the nation: New California law takes aim at unapproved stem cell procedures

Daily Briefing
  • California: Gov. Jerry Brown this week signed into law a bill (SB 512) that requires stem cell clinics that offer procedures that are not FDA approved to make that clear to consumers. Providers who offer such procedures must display a prominent notice and provide patients with a written statement stating that the procedures do not have federal regulatory approval. According to the bill's sponsor, state Sen. Ed Hernandez (D), more than 100 offices in California offer unproven, experimental stem cell treatments (Thielking, "Morning Rounds," STAT News, 10/5).

  • Ohio: Bob Baxter on Wednesday became the permanent CEO and president of Mercy Health-Toledo. Baxter, who has been with Mercy Health since 2010, has led Mercy Health-Toledo on an interim basis since June (Vaidya, Becker's Hospital Review, 10/4).

  • Wisconsin: Workers have begun construction on a new facility for Tomah Memorial Hospital. Officials have described the $66 million, 140,000 square-foot facility as "state-of-the-art." Construction is slated to finish by fall 2019, according to CEO Phil Stuart (Lagasse, Healthcare Finance News, 10/4).

Are you leading an evidence-based organization?

Despite the shift toward broad acceptance of evidence-based practice (EBP) among medical staff, over half of physicians report not actually using guidelines day-to-day when they are available. As a result, organizations continue to see tremendous variation in clinical practice—as well as in costs and outcomes.

Our infographic outlines four principles you can use to support EBP at your organization, along with action steps to implement each one and pitfalls to avoid along the way.

Download the Infographic

X
Cookies help us improve your website experience. By using our website, you agree to our use of cookies.